Pediatric Cancer Research Foundation 2024: Translational Research Grants

No Applicants // Limit: 1 // Tickets Available: 1 

These grants fund new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high- risk cancers. This Grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. Applicants must be a PhD and/or MD.

Grant Criteria and Eligibility:

• The probability of an advance in prevention, diagnosis or treatment for the near-term
• The novelty of the concept and strategy
• The clarity of presentation
• The overall plan for bringing the research findings to clinical application
• Experience, background, and qualifications of the investigators
• Adequacy of resources and environment (facilities, patients, etc.)
• PCRF only funds non-profit institutions and they must be located in the US.
• PCRF does not have citizenship requirements for our investigators. However, the Principal Investigator needs to be employed by a non-profit U.S. institution that has an affiliation with a hospital.
• Basic Science Research and Translational Grants require the applicant to be a PhD and/or MD.
• Emerging Investigator applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period.